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HIV-1 infection requires fusion of viral and cellular membranes in a reaction catalyzed by the viral envelope proteins gp120 and gp41. We
recently reported that efficient HIV-1 particle fusion with target cells is linked to maturation of the viral core by an activity of the gp41 cytoplasmic
domain. Here, we show that maturation enhances the fusion of a variety of recombinant viruses bearing primary and laboratory-adapted Env
proteins with primary human CD4+ T cells. Overall, HIV-1 fusion was more dependent on maturation for viruses bearing X4-tropic envelope
proteins than for R5-tropic viruses. Fusion of HIV-1 with monocyte-derived macrophages was also dependent on particle maturation. We conclude
that the ability to couple fusion to particle maturation is a common feature of HIV-1 Env proteins and may play an important role during HIV-1
replication in vivo.
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The life cycle of human immunodeficiency virus type 1
(HIV-1) consists of a series of molecular events effected by
both viral and cellular proteins. Assembly of infectious human
immunodeficiency virus type 1 (HIV-1) requires budding of the
immature, non-infectious particle and proteolytic maturation of
the core to render the particle infectious. Proteolytic cleavage
of the major structural polyprotein Gag occurs at specific sites
and in a defined order (Erickson-Viitanen et al., 1989;
Konvalinka et al., 1995; Krausslich et al., 1988; Tritch et al.,
1991). The resulting morphological transformation, termed
maturation, is essential for infectivity and leads to condensation
of the inner core and formation of the metastable capsid shell
that is capable of uncoating in the target cell (reviewed in Vogt,
1996). Inhibitors of the viral protease effectively block virus
maturation; the resulting immature virions are impaired for
early postentry steps of infection, including uncoating and
reverse transcription (Ashorn et al., 1990; McQuade et al.,
1990; Schatzl et al., 1991).0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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mediated by interactions of the viral protein gp120 on the
virion surface with CD4 and chemokine receptors on the target
cell. Fusion requires a series of binding events involving target
cell CD4, a coreceptor, and possibly other cell surface
molecules (reviewed in Pierson and Doms, 2003). Binding to
CD4 results in conformational changes in gp120, exposing a
binding site for a coreceptor on the target cell surface. The
engagement of coreceptor induces conformational changes in
the viral transmembrane protein gp41, leading to insertion of its
hydrophobic amino terminus into the target cell membrane and
ultimately resulting in membrane fusion. One of two major
coreceptors, CCR5 and CXCR4, is used by most strains of
HIV-1. CCR5 is expressed on T cells and macrophages as well
as immature dendritic cells (Lee et al., 1999). Transmission of
HIV-1 is restricted to CCR5-utilizing (‘‘R5-tropic’’) viral
strains, while X4-tropic and dual-tropic (R5X4) strains emerge
later in infected individuals (reviewed in Clapham and
McKnight, 2001). R5-tropic HIV-1 strains replicate efficiently
in primary T cells and macrophages whereas many X4-tropic
viruses replicate poorly in macrophages. The block to infection
of macrophages by some X4-tropic strains is likely to be at
entry (Broder and Berger, 1995; O’Brien et al., 1990; Yi et al.,
1998); however, a fusion defect has not been demonstrated6) 460 – 468
www.e
Fig. 1. Efficient fusion of X4 and R5-tropic HIV-1 depends on viral maturation.
(A) Mature HIV-1 NL-HxB reporter virions (filled symbols) and the
corresponding immature reporter virions (open symbols) were titrated on
SupT1-CCR5 target cells. Fusion was quantified as the ratio of blue to green
fluorescence resulting from cleavage of the h-lactamase substrate CCF2-AM.
Results are shown as the mean values of duplicate determinations as a function
of the quantity of virus added to the cells. The results are representative of at
least three independent experiments. (B) Assay of mature (filled symbols) and
immature (open symbols) reporter particles of the R5-tropic virus NL-
92BR020.4.
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evidence for a postentry block to infection by X4-tropic HIV-1
in macrophages (Huang et al., 1992; Schmidtmayerova et al.,
1998; Simmons et al., 1995).
We and others recently demonstrated that immature HIV-1
particles are impaired for fusion with target cells due to an
activity of the gp41 cytoplasmic domain (Murakami et al.,
2004; Wyma et al., 2004). Biochemical evidence suggested that
the gp41 CT is tightly associated with Gag in immature HIV-1
particles, suggesting a possible allosteric mechanism for
linking HIV-1 fusion competence to particle maturation. This
‘‘inside-out’’ regulation of HIV-1 fusion could play an
important role in the virus life cycle by preventing the entry
of immature, noninfectious particles, thereby enhancing the
overall efficiency of virus fusion events leading to infection. In
our previous study, we used HIV-1 encoding X4-tropic Env
and an immortalized human T cell line SupT1. Here, we extend
the analysis to chimeric HIV-1 viruses containing a variety of
primary isolate and laboratory HIV-1 Env proteins. In addition,
we have performed the fusion assays using T cell lines,
activated primary human T cells, and macrophages. The results
revealed that coupling of HIV-1 fusion to particle maturation is
a general feature of HIV-1 envelope proteins and is observed in
primary T cells and macrophages. Interestingly, the dependence
of fusion on particle maturation was more pronounced when
the virus used CXCR4 as a coreceptor than when entry occurs
through CCR5.
Results
The fusion of X4- and R5-tropic HIV-1 with a T cell line is
dependent on particle maturation
Using a novel assay of HIV-1 virus–cell fusion, we
previously showed that fusion of the X4-tropic cloned virus
HIV-1NL4-3 with SupT1 target cells is markedly reduced if the
particles are immature due to the presence of mutations that
prevent cleavage of Gag (Wyma et al., 2004). This assay relies
on delivery of active h-lactamase (BlaM) into the cytoplasm of
target cells via fusion of virions containing the enzyme.
Intracellular BlaM is then detected by loading the cells with
a fluorescent substrate (Cavrois et al., 2002). Expression of
CD4 and an appropriate coreceptor on the target cells is
required to generate a positive signal in the assay. The fusion
signal is also sensitive to highly specific inhibitors of HIV-1
fusion (such as T-20), establishing the specificity of the assay
for Env-catalyzed virus–cell fusion (Cavrois et al., 2002; our
unpublished observations). In this assay, a functional PR is
required to cleave the BlaM-Vpr reporter protein in order for
BlaM to be fully active (Wyma et al., 2004). Therefore, to
generate immature particles suitable for use in the fusion assay,
we used a virus containing mutations in the Gag cleavage sites
rather than in PR. The impaired maturation of HIV-1 particles
was dependent on the gp41 cytoplasmic tail as truncation of the
tail or pseudotyping by VSV-G rendered immature and mature
HIV-1 particles equally competent for fusion. Importantly,
these observations also demonstrated that the difference infusion observed with mature and immature HIV-1 was neither
an artifact of differences in sensitivity of the particles to the p24
ELISA (used for normalizing the virus input quantities) nor
was it due to differential incorporation of the BlaM-Vpr
reporter protein in the two viruses. The BlaM-Vpr assay is
currently the most specific and sensitive assay available to
quantify the fusion of HIV-1 particles with target cells and was
therefore the assay of choice for the current study. Our previous
conclusion that HIV-1 virus–cell fusion depends on virion
maturation has been independently confirmed by a study in
which the less sensitive and less quantitative ‘‘fusion from
without’’ assay was employed (Murakami et al., 2004).
We wished to determine whether the effect of maturation on
HIV-1 fusion extends to HIV-1 viruses encoding Env proteins
with a tropism for CXCR4 or CCR5. To test this, we analyzed a
series of NL4-3-based chimeric proviral clones encoding Env
proteins from the HIV-1 primary and laboratory-adapted isolates
ADA, BaL, 89.6, 91US005.11, 92MW965.26, 92RW020.5,
92BR020.4, 92UG021.6, 92UG024.2, or 92HT599.24 (Zhang
et al., 2002). To quantify the dependence of fusion of these
viruses on particle maturation, we generated the corresponding
immature mutants by transferring a restriction fragment contain-
ing the cleavage inactivating mutations in Gag. BlaM-Vpr
Fig. 2. Immunoblot analysis of mature and immature virus particles. Samples o
the indicated viruses were diluted to equivalent p24 concentrations (as
determined by ELISA), pelleted, and analyzed by SDS-PAGE followed by
immunoblotting with antibodies specific for CA, gp41, BlaM, and cyclophilin
A (CypA). Panels A and B represent separate blots.
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on SupT1-CCR5 cells. Virus stocks were normalized by p24
antigen-capture sandwich ELISA following detergent disruption
of the virions to solubilize the hyperstable cores, thereby
rendering them detectable by the ELISA [We have previously
shown that this procedure is effective and renders the ELISA
nearly as sensitive for the immature particles as the mature
virions (Wyma et al., 2000, 2004)]. The results revealed that all
of the immature particles were less able to fuse with the cells than
their corresponding mature viruses, though the magnitude of the
fusion defect varied among the viruses (Fig. 1 and Table 1).
Overall, fusion of the R5-tropic viruses with SupT1-CCR5 cells
was significantly less dependent on maturation than the X4-
tropic viruses. However, within each group, the magnitude of the
fusion defect varied considerably (Table 1). Analysis of the
pelleted virions by immunoblotting revealed similar quantities
of gp41, cyclophilin A, and cleaved BlaM in the mature and
immature particles, thus confirming the accuracy of the p24
assay used for normalization of the particles (Fig. 2). (For some
of the viruses, the immature particles appeared to have higher
quantities of gp41. This suggests that the effect of maturation on
fusion may be somewhat underestimated for these viruses.)
Collectively, these results suggested that the degree to which
HIV-1 fusion is coupled to particle maturation depends on the
coreceptor used for HIV-1 entry.
To further test the hypothesis that the maturation depen-
dence of HIV-1 fusion is linked to coreceptor specificity, we
took advantage of the R5X4-tropic Env protein from HIV-189.6.
Because most human lines express endogenous CXCR4, we
employed the mouse fibroblast cell line 3T3 encoding human
CD4 and either CXCR4 (3T3-CD4-CXCX4) or CCR5 (3T3-
CD4-CCR5) (Deng et al., 1997). HIV-1 cannot fuse with 3T3-
CD4 cells lacking a functional coreceptor. Accordingly, the
fusion signals obtained with either 3T3 cells or 3T3-CD4 cells
were at background levels (data not shown). Control assays
using X4- and R5-tropic reporter viruses (pNL4-3 and pNL-
BaL, respectively) demonstrated the permissiveness of 3T3-
CD4-CXCR4 and 3T3-CD4-CCR5 for entry by the virusesTable 1
Maturation-dependence of HIV-1 virus-cell fusion
Virus Coreceptor Fusion efficiency Ratioa
(Ma/Im)
Mature (Ma) Immature (Im)
NL-91US005.11 CCR5 0.86 0.18 3.2 T 1.6
NL-92MW965.26 CCR5 0.65 0.16 3.7 T 0.74
NL-92RW020.5 CCR5 0.53 0.10 2.8 T 1.7
NL-92BR020.4 CCR5 0.66 0.21 2.2 T 0.85
NL-ADA CCR5 2.25 0.32 5.6 T 2.6
NL-BaL CCR5 0.76 0.23 2.9 T 1.1
Average 3.4 T 1.2b
NL-92UG024.2 CXCR4 2.40 0.34 9.5 T 3.2
NL-92UG021.6 CXCR4 0.99 0.18 10.2 T 2.0
NL-92HT599.24 CXCR4 2.32 0.28 7.1 T 3.7
NL-HxB CXCR4 4.36 0.35 10.3 T 4.0
NL4-3 CXCR4 2.99 0.28 7.7 T 3.5
Average 9.0 T 1.5b
a Mean values of four independent determinations T one standard deviation.
b p < 0.005.fwith the correct tropism (Fig. 3A). By contrast, dual-tropic NL-
89.6 virions were capable of fusing with both cell types.
However, fusion of the immature MA/p6-89.6 virions was
more efficient when the target cells expressed CCR5 than when
CXCR4 was expressed (Figs. 3B and C). Thus, fusion of the
dual-tropic virus was more dependent on particle maturation
when entry was mediated through CXCR4 (Fig. 3D). The
difference was not a result of an overall decreased permissive-
ness of the CXCR4-expressing cells because the fusion of the
mature NL-89.virus with these cells was more efficient than
with CCR5-expressing cells. Flow cytometric analysis demon-
strated that the two cell lines expressed similar levels of cell-
surface CD4 (data not shown). Although the cells were
engineered with CXCR-4 or CCR-5 expressed from a vector
under control of the MLV promoter, it remains possible that the
levels of these coreceptors differ on the two cell lines.
Collectively, these results support the conclusion that the
degree to which HIV-1 fusion depends on particle maturation is
greater for viruses that use CXCR4 than those that use CCR5
for entry. When we attempted to further test this hypothesis
using dual-tropic viruses with primary T cells and antagonists
to either CXCR4 or CCR5, we found that the inhibition of
virus–cell fusion by these inhibitors was only partial at the
Fig. 3. The magnitude of the dependence of HIV-1 fusion on particle maturation varies with coreceptor usage. (A) Fusion of the HIV-1 reporter virions NL4-3 (X4-
tropic) and NL-BaL (R5-tropic) with the cell lines 3T3-CD4-CXCR4 and 3T3-CD4-CCR5. The fusion efficiency was expressed as a function of the fluorescence
ratio per nanogram of p24 input virus. (B and C) Fusion of mature (filled symbols) and immature (open symbols) R5X4-tropic HIV-1 particles with 3T3-CD4 cells
expressing either CXCR4 (B) or CCR5 (C). Env-defective HIV-1 reporter particles () were included as negative control. (D) Summary of the fusion data from
panels B and C. The relative fusion efficiency was calculated as the blue/green fluorescence ratio as a function of the p24 concentration in the virus inocula.
Fig. 4. The requirement for HIV-1 maturation for efficient virus–cell fusion
extends to primary CD4+ T cell targets. (A) Fusion R5-tropic virus NL-
92RB020.4 (filled symbols) and the corresponding immature virions (open
symbols) with primary CD4+ T cells. (B) Fusion of X4-tropic NL-HxB and the
corresponding immature virions with primary CD4+ T cells. The results are
representative of three independent experiments.
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were unable to obtain meaningful results using this approach.
Immature HIV-1 particles are impaired for fusion with
activated primary CD4+ T cells
The studies thus far were performed with established cell
lines, and the results could reflect an unusual property of
immortalized cells. If the dependence of HIV-1 fusion on virion
maturation is physiologically relevant, it should also be
apparent with natural targets of HIV-1 infection such as
primary T cells and macrophages. To study HIV-1 fusion with
primary T cells, we purified CD4+ T cells and activated them
with bacterial superantigen (SEB) and mitomycin C-killed
allogeneic PBMC. This cell system minimizes variability
resulting from CD8+ T cells and macrophages that secrete
inhibitors of HIV-1 fusion. Furthermore, the use of a T-cell
receptor ligand (SEB) and antigen-presenting cells is a more
physiological method of T-cell activation than is PHA-
mediated cross-linking of T-cell surface molecules. An
example of the results is shown in Fig. 4. For all of the
viruses tested, the immature virions were impaired for fusion
with primary CD4+ T cells (Table 2). Furthermore, the overall
degree to which fusion depended on maturation was greater for
X4-tropic HIV-1 than for R5-tropic viruses, but there was a
significant degree of variation within each group. We conclude
that the dependence of HIV-1 fusion on particle maturation
extends to activated CD4+ primary human T cells and that the
Table 2
Fusion of mature and immature HIV-1 virions with primary CD4+ human T cells
Virus Coreceptor
usage
Donor 1 Donor 2
Mature (Ma) Immature (IM) Ratio (Ma/IM) Mature (Ma) Immature (IM) Ratioa (Ma/IM)
NL-91US005.11 R5 0.42 0.19 2.2 0.25 0.17 1.5
NL-92MW965.26 R5 0.78 0.24 3.3 0.38 0.11 3.5
NL-92BR020.4 R5 0.34 0.22 1.6 0.32 0.19 1.7
NL-ADA R5 0.19 0.12 1.6 0.16 0.14 1.1
NL-BaL R5 0.18 0.05 3.8 0.10 0.06 1.8
Average 2.5 T 1.0b 1.9 T 0.8c
NL-92UG021.6 X4 1.1 0.08 13.7 0.9 0.15 6.3
NL-92HT599.24 X4 0.63 0.26 2.4 0.7 0.24 2.9
NL-HXB X4 3.2 0.29 11.2 3.0 0.17 17.6
NL4-3 X4 2.2 0.25 9.0 1.8 0.24 7.6
Average 9.1 T 4.8b 8.6 T 6.3c
a Mean values of four determinations.
b p < 0.05.
c p < 0.05.
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than that of R5-tropic HIV-1.
Immature HIV-1 particles are impaired for fusion with
monocyte-derived macrophages
We next asked whether fusion of HIV-1 with macrophages
also depends on particle maturation. For this purpose, we
generated macrophages by differentiation of monocytes that
were purified by negative selection from peripheral blood
mononuclear cells of healthy donors. Most X4-tropic HIV-1
strains do not efficiently enter macrophages; therefore, we
chose the R5-tropic viruses pNL-BaL and pNL-AD8 along
with their corresponding MA/p6 immature viruses for analysis.
The fusion assay produced a dose-dependent signal with both
NL-BaL and NL-AD8, demonstrating the utility of the reporter
fusion assay with monocyte-derived macrophages (Fig. 5). The
signal was inhibited by T-20 and was not observed with X4-
tropic (HIV-1NL4-3) or with envelope-deficient virions, thus
confirming that the signal reflected coreceptor-dependent HIV-
1 fusion. Relative to mature virions, the immature particles
were approximately three-fold less active for fusion (Table 3).
We conclude that efficient HIV-1 fusion with monocyte-
derived macrophages also depends on particle maturation.
Discussion
In a previous study, we established that HIV-1 fusion is
regulated at the level of particle maturation. Immature HIV-1
particles containing uncleaved Gag protein were impaired for
fusion with target cells. The fusion impairment was linked to
an activity of the gp41 cytoplasmic tail (CT), as demonstrated
by the equivalent ability of immature and mature HIV-1
particles lacking the CT to fuse with target cells. The previous
study was performed with the X4-tropic NL4-3 HIV-1 strain
and the SupT1 human T cell line. In the present study, we have
shown that the dependence of HIV-1 fusion on HIV-1
maturation extends to HIV-1 particles bearing R5- and X4-
tropic Env proteins and to fusion with primary T cells andmacrophages. These results suggest that coupling of fusion to
particle maturation could be important for HIV-1 replication in
vivo. The ability to prevent premature fusion may be of
particular significance in the context of active replication in
lymphoid tissues of high target cell density, such as lymph
node and intestinal lamina propria. In such tissues, cell-to-cell
transmission is likely to be a predominant mode of virus
spread; in this context, a mechanism to allow the viral core
enough time to mature could play a pivotal role in maximizing
the overall efficiency of replication.
Through analysis of a series of chimeric viruses encoding
primary isolate and laboratory-adapted Env genes, we also
observed that the dependence of HIV-1 fusion on maturation is
generally lower for R5-tropic Env than for X4-tropic Env
proteins. Overall, the viruses that fused less efficiently were
also less dependent on maturation for fusion, suggesting the
possibility that the dependence of fusion on maturation may be
more related to overall fusion activity than specifically to viral
tropism. We cannot exclude this possibility; however, we
observed that an R5X4-tropic virus, NL-89.6, was less
dependent on maturation when the target cells expressed
CCR5 than when the corresponding target cells expressing
CXCR4 were used, despite efficient fusion of the mature
particles with cells expressing either coreceptor. Flow cyto-
metric analysis demonstrated that the 3T3-CD4 cell lines used
in this experiment expressed similar levels of CD4. However,
we have not quantified the coreceptor levels on the surface of
the cells, and they could be present at different levels despite
the fact that the coreceptors were expressed using the same
retroviral vector (Deng et al., 1997). Based on these results and
considerations, we conclude that the requirement for linking
fusion to maturation may be less stringent for R5-tropic HIV-1
strains.
In this study, we employed chimeric viruses that did not
contain complete swaps of the viral Env genes but retain the C-
terminal 106 amino acids of HIV-1NL4-3. It remains possible
that this region of the gp41 CT has a significant effect on the
fusion efficiency as well. Although this sequence is well
conserved among HIV-1 isolates, it contains two short regions
Table 3
Fusion of mature and immature HIV-1 with monocyte-derived macrophages
Donor 1 Donor 2
Mature Immature Ratio (Ma/IM) Mature Immature Ratio (Ma/IM)
NL-BaL 5.6 2.2 2.6 5.3 1.9 2.8
NL-ADA 3.6 0.75 4.8 1.9 0.47 4.2
Fig. 5. Fusion of immature HIV-1 particles with primary monocyte-derived
macrophages (MDM) is impaired relative to mature HIV-1. Reporter viruses
encoding Env from HIV-1BaL (A) or HIV-1ADA (B) were titrated on primary
MDM and the extent of fusion determined using the BlaM reporter assay.
Controls included Env-deficient HIV-1 (X) and assays of the mature viruses in
which the gp41-specific fusion inhibitor T-20 was added (open symbols). X4-
tropic HIV-1NL4-3 was incapable of fusing with MDM (C).
J. Jiang, C. Aiken / Virology 346 (2006) 460–468 465that exhibit considerable variability. A region of sequence
variation exists near the transmembrane domain; this region is
varied in our chimeras. However, the second region contains a
small insertion in some isolates but is beyond the chimera
junction in the viruses used in this study. Analysis of the
function regions of the gp41 CT involved in inhibiting
immature HIV-1 fusion is currently underway in our laboratory.
The present study was also limited to analysis of a single Gag
protein (from HIV-1NL4-3), and it is conceivable that the degree
to which HIV-1 fusion is impaired in immature particles is
influenced by sequence variations in Gag.
The mechanism by which the gp41 cytoplasmic tail
inhibits the fusion of immature HIV-1 particles remains
unclear. We have previously proposed two models, both of
which are based on our finding that gp41 is strongly
associated with Gag in immature HIV-1 particles (Wyma et
al., 2000). In the first, binding of full-length Gag to thegp41 CT might inhibit the receptor-induced conformational
changes in the Env trimer required for fusion. Currently,
there is no direct evidence in support of this model,
although ample evidence indicates that loss of the CT
may decrease the energy required for triggering the
conformational changes leading to fusion. Effects of CT
truncations on Env epitope exposure have been detected on
cells expressing SIV or HIV-1 envelope proteins (Edwards et
al., 2002; Spies et al., 1994). Furthermore, truncation of the
CT is also associated with the ability of HIV-1 to infect
CD4-negative cells (Hoffman et al., 1999) and with cell
culture adaptation of SIV for replication in a human T cell
line (Chakrabarti et al., 1989; Kodama et al., 1989). Finally,
truncation of the gp41 CT enhances the overall rate of cell–
cell fusion (Abrahamyan et al., 2005) and renders HIV-1
more sensitive to neutralizing antibodies, indicating that the
CT controls the conformation of gp120 on the surface of the
particle (Edwards et al., 2002). Despite these observations,
there is currently no direct evidence that mature and
immature HIV-1 particles differ with respect to gp120 or
gp41 conformations or in the capacity to undergo receptor-
induced Env conformational changes.
In the second model, the Env conformational changes
required for fusion may be induced normally on immature
HIV-1 particles, but the stable association of gp41 with Gag
may constrain the ability of Env to move laterally within the
viral membrane. It is likely that the Env trimers on immature
HIV-1 particles are limited in their ability to move relative to
one another. If fusion depends on a critical density of Env–
receptor complexes at the viral–cell synapse, the impaired Env
mobility on surface of an immature HIV-1 particle could
significantly reduce the probability that fusion will result from
an individual virus–cell encounter. Removal of the gp41 CT
releases Env from Gag on immature particles (Wyma et al.,
2000), potentially allowing Env to move within the viral
membrane and enhancing the ability of immature virions to
increase the local density of trimeric Env complexes at the
virus–cell synapse.
Our finding, that viral entry via CCR5 is less dependent on
core maturation, can be reconciled with either model. The
association of R5-tropic gp120 with CCR5 is generally of
higher affinity than that of X4-tropic gp120 with CXCR4.
Although the number of Env trimers required for HIV-1 entry
is currently unresolved, a requirement for multiple CCR5
molecules for HIV-1 infection has been reported (Kuhmann et
al., 2000). It is possible that engagement of fewer coreceptor
molecules is sufficient for entry of R5-tropic virus than for X4-
tropic HIV-1, and this results in a decreased dependence of R5-
tropic HIV-1 fusion on particle maturation.
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Cells and culture conditions
293T, 3T3-CD4-CXCR4, and 3T3-CD4-CCR5 cells were
cultured in Dulbecco’s modification of Eagle medium
(Cellgro) supplemented with 10% fetal bovine serum
(FBS, Hyclone, Inc.) and penicillin plus streptomycin
(Cellgro) at 37 -C and 5% CO2. SupT1-CCR5 cells were
cultured in RPMI 1640 supplemented with 10%FBS and
penicillin plus streptomycin. Puromycin (1 Ag per ml) was
added to the culture medium to maintain CCR5 expression
in 3T3-CD4-CCR5 cells and SupT1-CCR5. Human periph-
eral mononuclear cells (PBMCs) were purified from fresh
blood by banding on Ficoll-Hypaque (Amersham Bio-
sciences; 30 min, 800  g, 25 -C). Primary human CD4+
T cells were purified from PBMCs by positive selection
with anti-CD4 Dynabeads and subsequent release using
Detachabead (Dynal Biotech). Cells were cultured in
RPMI1640 (Gibco) supplemented with 10% fetal bovine
serum (HyClone), MEM amino acids, l-glutamine, MEM
vitamins, sodium pyruvate (Gibco), and penicillin plus
streptomycin (Cellgro) and were subsequently activated with
bacterial superantigen staphylococcal enterotoxin B (SEB;
100 ng/ml) and mitomycin C-killed PBMC from another
donor (10:1 PBMC/CD4+ cell ratio), as previously described
(Lundquist et al., 2002). Three days following stimulation,
cells were split 1:2 in medium containing interleukin-2 (IL-
2; NIH AIDS Research and Reference Reagent Program;
200 U/ml final concentration). Cultures were then split 1:2
every 2 days in IL-2 medium and infected with HIV-1 at 7
days poststimulation. For generating primary human macro-
phages, monocytes were purified from human PBMCs by
negative selection (Dynal), and activated and cultured as
previously described. Monocytes were cultured at a cell
concentration of 106 per ml in DMEM, supplemented with
10% fetal bovine serum (HyClone), MEM amino acids, l-
glutamine, MEM vitamins, sodium pyruvate (Gibco), and
penicillin (100 U/ml), streptomycin (100 mg/ml), and 50 ng/
ml rhGM-CSF (R&D systems) and maintained at 37 -C in a
humidified atmosphere supplemented with 5% CO2. To
obtain monocyte-derived macrophages (MDM), cells were
allowed to adhere to plastic and cultured for 6 days to allow
differentiation.
HIV-1 proviral constructs
The viral mutants used in this study were derived from
the wild-type infectious HIV-1 proviral clone pNL4-3. NL4-
3-based proviral constructs encoding Env genes from X4-
tropic viruses 92UG021.6, 92UG024.2, 92HT599.24 and
pNL HXB, R5-tropic proviral pNL ADA, 91US005.11,
92MW965.26, 92RW020.5, 92BR020.4, and dual tropic
proviral pNL89.6, were obtained from P. Bieniasz and have
been described (Zhang et al., 2002). The pNL-MA/p6 clone
produces immature HIV-1 particles containing mutations
inactivating all of the known Gag cleavage sites, and waspreviously described (Wyma et al., 2004). MA/p6 mutant
viruses containing other envelope genes were created by
transfer of the BssHII–EcoRI fragment from pNL-MA/p6
into the NL4-3-based chimeric viruses.
Production of HIV-1 stocks
To produce HIV-1 reporter viruses for quantifying virus–
cell fusion, we transfected 293T cells in 100-mm-diameter
dishes with 20 Ag of proviral DNA and 7 Ag of pMM310,
encoding a BlaM-Vpr fusion protein, as previously described
(Wyma et al., 2004). Virus stocks were harvested 36 to 48
h after transfection and clarified through 0.45-Am-pore-size
syringe filters, and aliquots were buffered with HEPES (10
mM) prior to storage at 80 -C. HIV-1 stocks were assayed
for p24 by ELISA (Wehrly and Chesebro, 1997) after
incubation for 10 min at 95 -C in the presence of 1%
sodium dodecyl sulfate (SDS) to disrupt immature particles.
Samples were subsequently diluted by at least 100-fold to
prevent SDS interference with antigen–antibody interactions
in the ELISA.
Virus–cell fusion assay
The virion-based fusion assay was performed as de-
scribed previously (Cavrois et al., 2002; Wyma et al., 2004).
Briefly, HIV-1 particles carrying a h-lactamase reporter
protein were produced by cotransfection of 293T cells with
cloned HIV-1 proviral DNA and pMM310, a construct
encoding h-lactamase (BlaM) fused to the amino terminus
of the virion protein Vpr (BlaM-Vpr), thereby targeting
BlaM to the virion. To assay fusion, we inoculated SupT1-
CCR5 cells (100,000) with dilutions of viruses in 100-
Al total volumes and incubated them at 37 -C for 2 h to
allow virus–cell fusion. In some experiments, T-20 (400
nM) was added as a control, and all of the experiments
were performed with Env-defective particles in parallel as a
control to quantify the background in the assay. In this way,
the potential for artifacts resulting from low signal/noise
ratios was minimized. CCF2/AM (20 AM; Aurora Bios-
ciences Corp.) was added, and the cultures were incubated
for 14 h at room temperature. Cells were pelleted and
resuspended in phosphate-buffered saline (PBS), and the
fluorescence was measured at 447 and 520 nm in a
microplate fluorometer (BMG Fluostar) with excitation at
409 nm. Fluorescence ratios were calculated after subtraction
of the average background fluorescence of control cultures
containing no virus (blue values) and wells containing PBS
(green values). Duplicate determinations were performed for
each virus dilution, and the fusion values typically agreed to
within 10%. For quantitative comparison of fusion between
viruses, the fusion was expressed as a function of the
amount of p24 in the respective inoculum. All of the fusion
assays were performed using a range of virus dilutions to
obtain signals at which the assay was not saturated. For
each virus, the value used in the calculation of fusion
efficiency was obtained from the maximal virus dose that
J. Jiang, C. Aiken / Virology 346 (2006) 460–468 467gave a fusion signal that was within the linear range of the
titration curve. These values were obtained from duplicate
samples (which were normally within 10% of one another),
and signals obtained with Env-defective virus were sub-
tracted from the results to determine the specific fusion
efficiencies, which were then used to calculate the ratio of
mature to immature fusion efficiency. The results from
several experiments were used to calculate a mean and
standard deviation for the ratios of the mature and immature
HIV-1 fusion efficiency.
Immunoblotting of viral lysates
Viral stocks were normalized by p24 ELISA and pelleted
through a cushion of 20% sucrose in STE buffer in a
Beckman TLA-55 rotor at 45,000 rpm for 30 min. The
viral pellets were lysed in SDS-PAGE sample buffer, heated
at 95 -C for 5 min, and subjected to electrophoresis onto
4–20% polyacrylamide gels containing SDS (BioRad).
Proteins were transferred to PVDF and the blots were
probed with rabbit antibody to CypA (from Louis Hender-
son) and mouse monoclonal antibodies to CA (183-H12-5C)
and BlaM (QED Bioscience Inc.). Gp41 was detected by
human monoclonal antibody 246-D (NIH AIDS Research
and Reference Reagent Program). Protein bands were
detected using the LI-COR Odyssey imaging system after
probing with the appropriate IR dye-conjugated secondary
antibodies.
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